BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Amniocentesis
,
Fluoxetine
,
rs2476601
,
FGF21
,
Coagulation
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Spinal muscular atrophy type II
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
BICD2
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Bicaudal-D protein
Predicted Gene Targets for miR-340
minus-end-directed organelle transport along microtubule
microtubule anchoring at microtubule organizing center
cytoskeletal adaptor activity
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Spinal muscular atrophy disorders
Explore Curated Studies Results
Literature
Most Relevant Literature
Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-…
Impaired mandibular function in spinal muscular atrophy type II: need for early recognition.
Prevalence and risk factors for feeding and swallowing difficulties in spinal muscular atrophy types…
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and…
Physical characteristics and applicability of standard assessment methods in a total population of s…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
Clinical Assessment of Spinal Muscular Atrophy Type II and III (SMA Europe)
Trial Evaluating the Interest of Noninvasive Ventilation in NAVA Mode in Respiratory Decompensations…
A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ